Results 271 to 280 of about 51,902 (295)

Thromboembolism and Janus Kinase Inhibitors

Drug Safety, 2020
Fowzia Ibrahim, David L. Scott
openaire   +3 more sources

Janus kinases inhibitors

Cahiers Santé Médecine Thérapeutique, 2022
El Mehdi Boudhar, M El Mandour, Abdelhafid Elguich, Hajar Sahimi, Hasna Hassikou   +4 more
openaire   +1 more source

Le filgotinib (Jyseleca®), un inhibiteur des Janus kinases

Actualites Pharmaceutiques, 2022
Sébastien Fauré
exaly  

Role of Janus Kinase Inhibitors in Therapy of Psoriasis

Journal of Clinical Medicine, 2021
Sylwia Słuczanowska-Głąbowska, Kamila Szumilas, Andrzej Pawlik   +2 more
exaly  

Janus Kinase

2006
openaire   +2 more sources

JAKs in pathology: Role of Janus kinases in hematopoietic malignancies and immunodeficiencies

Seminars in Cell and Developmental Biology, 2008
William Vainchenker, Stefan N Constantinescu   +1 more
exaly  

Janus Kinase

2011
openaire   +1 more source

Janus Kinases

2008
openaire   +1 more source

Janus Kinases (JAK)

2012
Marissa K. Caldow, David Cameron-Smith
openaire   +1 more source

New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease

Scandinavian Journal of Gastroenterology, 2015
Gionata Fiorino, Mariangela Allocca, Alessandro Repici   +2 more
exaly